Weight Loss with LCHAD Deficiency in South Africa

Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency is a rare inherited disorder that blocks the breakdown of long-chain fatty acids — the dominant fat type in most diets. If you have LCHAD Deficiency and want to lose weight in South Africa, you are working with a paradox: your body cannot burn the long-chain fats stored in your adipose tissue as efficiently as a healthy person can, and the dietary fat you eat must be tightly managed. This guide explains the metabolic realities, which diets are dangerous, and how to achieve a safe and meaningful caloric deficit with LCHAD.

What Is LCHAD Deficiency?

LCHAD Deficiency is caused by mutations in the HADHA gene, which encodes the alpha subunit of the mitochondrial trifunctional protein (MTP). MTP is a large enzyme complex that catalyses three steps in the beta-oxidation of long-chain fatty acids (those with 12–18 carbons). The most common pathogenic variant, p.Glu510Gln, accounts for the majority of cases worldwide, including in South Africa.

When LCHAD activity is absent or severely reduced, long-chain fatty acids accumulate as toxic 3-hydroxy-acylcarnitines. These compounds damage the retina (causing progressive retinopathy and potential blindness), peripheral nerves (causing painful neuropathy), cardiac muscle (cardiomyopathy), and skeletal muscle (causing rhabdomyolysis — acute muscle breakdown with myoglobin release that can cause kidney failure).

An important genetic feature: mothers who are carriers of one HADHA mutation (heterozygous carriers) face a significant risk of Acute Fatty Liver of Pregnancy (AFLP) when pregnant with an affected fetus. This is because the affected fetus's fat metabolites overflow into the maternal circulation and overwhelm the carrier mother's slightly reduced MTP activity. South African women who experienced AFLP during pregnancy should ensure they and their children have been tested for LCHAD Deficiency.

LCHAD Deficiency is distinct from isolated MCAD Deficiency (which affects medium-chain fats) and from complete MTP Deficiency (which affects all three MTP enzyme activities and tends to have a more severe phenotype).

The Dietary Foundation: Low Long-Chain Fat, High MCT

The cornerstone of LCHAD dietary management is a very low long-chain fat diet supplemented with MCT oil. This is the opposite of the popular keto or high-fat dietary approaches, and it is the most important thing to understand about LCHAD nutrition.

• Long-chain fat (LCT) restriction: Long-chain fats — found in red meat, chicken skin, full-fat dairy, cooking oils (olive oil, sunflower oil, palm oil), avocado, and nuts — are the direct substrate of the blocked enzyme. Dietary long-chain fat is limited to the essential fatty acid minimum needed to prevent EFA deficiency, typically supplying no more than 10–20% of total energy from long-chain fats (versus the 30–40% of a standard diet).
• MCT oil supplementation: Medium-chain triglycerides (C8, C10) are processed by a different enzyme pathway (MCAD, not LCHAD) and bypass the enzymatic block. MCT oil provides a major caloric energy source and is the primary dietary fat in LCHAD management. MCT-enriched formula or food-grade MCT oil (caprylic/capric acid blend) is prescribed by the metabolic team.
• Essential fatty acids: Because long-chain fats are restricted, DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), and linoleic acid must be supplemented. DHA is particularly critical for retinal health — an already vulnerable organ in LCHAD. DHA supplementation in LCHAD patients has been shown to slow retinal deterioration. Your metabolic team will prescribe specific EFA supplements.

Why Common Weight Loss Diets Are Dangerous with LCHAD

• High-fat diets and ketogenic diet: Keto diets are built around dietary fat as the primary energy source, with the majority coming from long-chain fats. This directly loads the blocked enzyme pathway. Standard keto is contraindicated in LCHAD. Even "MCT keto" — which uses MCT oil as the primary fat — would require extremely careful management and is only appropriate under specialist guidance.
• Fasting and intermittent fasting: During fasting, fat stores are mobilised for energy. In a healthy person, long-chain fats from adipose tissue enter beta-oxidation normally. In LCHAD, mobilisation of stored long-chain fats floods the blocked pathway, generating toxic 3-hydroxy-acylcarnitines. Prolonged fasting can trigger rhabdomyolysis — acute skeletal muscle breakdown presenting as severe muscle pain, dark (tea-coloured) urine, and potentially acute kidney failure. Intermittent fasting protocols (16:8, OMAD, extended fasts) are contraindicated.
• Exercise-induced rhabdomyolysis risk: Intense or prolonged exercise mobilises long-chain fats from both adipose tissue and intramuscular stores. Unprotected sustained aerobic exercise (long runs, long cycling sessions) without adequate carbohydrate fuelling is a major risk for rhabdomyolysis in LCHAD patients. Exercise is valuable and safe when properly fuelled — but must not be used as the primary driver of a large caloric deficit.
• Full-fat cooking in olive oil or sunflower oil: Unlike in other conditions, these standard "healthy" cooking fats are high in long-chain fatty acids (oleic acid C18:1, linoleic acid C18:2) and must be restricted in LCHAD. Cooking with small measured amounts of MCT oil or using cooking methods that minimise added fat (steaming, grilling, boiling) is preferred.
• Fatty fish (salmon, sardines, mackerel): Despite being rich in beneficial omega-3 fats, fatty fish contain high amounts of long-chain fats. White fish (hake, tilapia, snoek) cooked without skin and without added oil is safer. Fatty fish can be included in small, measured quantities within the long-chain fat budget and is the primary natural DHA source.

Safe Caloric Deficit for LCHAD

Target caloric deficit: 300–400 kcal/day in stable, well-controlled LCHAD patients. This achieves 0.3–0.4 kg of fat loss per week. The deficit is achieved primarily by reducing refined carbohydrates, sugary beverages, and long-chain fat intake — while maintaining the MCT oil allocation and protein intake.

Weight loss in LCHAD is complicated by the fact that mobilisation of stored long-chain fat creates metabolic stress. The body does release stored triglycerides during a caloric deficit, and in LCHAD those stored fats are long-chain. A small deficit keeps this mobilisation rate low enough to be manageable by alternative pathways and residual enzyme activity. A large deficit accelerates fat mobilisation to a rate that may exceed the system's capacity, risking decompensation.

Exercise Protocol for LCHAD

Exercise is important for metabolic health and weight management, but requires a specific protocol to prevent rhabdomyolysis:

• Always eat before exercise: A carbohydrate-containing meal or snack 30–60 minutes before any exercise session. Carbohydrates are the safe fuel for LCHAD during exercise; they spare the mobilisation of long-chain fat stores.
• During exercise lasting more than 20–30 minutes: Consume carbohydrates — glucose drink, sports drink, banana — every 20–30 minutes. MCT oil taken before exercise can also provide supplemental fuel through the intact pathway, but discuss this with your metabolic team.
• After exercise: Carbohydrate-rich recovery snack within 30 minutes.
• Avoid high-intensity sustained cardio: Short bursts are safer than prolonged steady-state exercise. Resistance training (weights) is generally well-tolerated when carbohydrate-fuelled.
• Warning signs: Muscle pain, weakness, or dark urine during or after exercise are red flags for rhabdomyolysis. Stop immediately and seek emergency assessment.

Macronutrient Strategy

• Protein: Unrestricted in principle — LCHAD does not affect protein metabolism. Lean protein sources (chicken breast without skin, hake, egg whites, low-fat cottage cheese, legumes) provide satiety and maintain muscle mass during fat loss. Avoid very high fat protein sources (fatty red meat, fried chicken, full-fat dairy).
• Carbohydrates: The primary safe energy source. Aim for 50–60% of total calories from carbohydrates. Pap, rice, bread, potatoes, fruit, and vegetables are all appropriate. During weight loss, portion control of carbohydrates (specifically refined and high-calorie carbohydrates) creates the deficit without affecting metabolic safety.
• Long-chain fat: Minimised to the essential minimum. Count every gram. Use small measured amounts (1–2 teaspoons maximum per meal) where required for cooking or essential fatty acid needs.
• MCT oil: Prescribed by your metabolic team. This is your primary supplemental fat and must not be reduced during weight loss without guidance. MCT is calorically dense (8.3 kcal/g) — if weight loss stalls, MCT volume may be an area to discuss adjusting with your dietitian.

Retinopathy and Neuropathy: Additional Reasons to Get Weight Right

LCHAD causes progressive retinal damage (leading to visual impairment or blindness in severe cases) and peripheral neuropathy. Excess body weight is associated with accelerated cardiovascular risk and worse neuropathic outcomes. Achieving a healthy weight is therefore directly relevant to the trajectory of these LCHAD-specific complications — not just general health.

DHA supplementation (as part of EFA management) also has retinal-protective effects in LCHAD. Ensure your DHA supplement is maintained or increased during any dietary change, since even greater restriction of long-chain fish fats during weight loss may reduce natural DHA intake further.

Practical South African Food Choices

• Safe protein sources: Skinless chicken breast (grilled, not fried), hake (grilled or steamed), egg whites, very lean beef mince (trimmed of visible fat), lentils, beans, low-fat cottage cheese.
• Safe carbohydrates: Pap (dry cooking method without added butter or oil), brown rice, sweet potato, butternut, bread (with very minimal spread), fruit.
• Vegetables: All non-starchy vegetables are excellent — high volume, low calorie, essentially fat-free. Cabbage, spinach, broccoli, tomatoes, carrots, green beans are all safe and filling.
• Avoid or minimise: Red meat, chicken with skin, full-fat dairy (cheese, full-cream milk, butter), avocado, nuts, seeds, cooking oils (especially in quantity), coconut products, fatty fish in large portions.
• Rooibos tea: A perfect beverage — calorie-free and fat-free. Safe to drink throughout the day.

Monitoring During Weight Loss

• Plasma acylcarnitines (3-OH-acylcarnitines): The primary biomarker of LCHAD metabolic control. Elevated long-chain 3-OH-acylcarnitines (C16-OH, C18:1-OH) indicate that long-chain fat oxidation stress is increasing. Check at baseline and every 8 weeks during active weight loss.
• Creatine kinase (CK): Elevated CK indicates muscle breakdown. A CK above 1 000 U/L warrants review of exercise intensity and fat intake. Values above 10 000 U/L in the setting of dark urine represent rhabdomyolysis requiring emergency management.
• Renal function (creatinine, eGFR): Particularly important if rhabdomyolysis risk is elevated.
• Essential fatty acid levels: DHA and arachidonic acid (AA) should be checked every 6–12 months. Low DHA correlates with faster retinal deterioration.
• Ophthalmology review: Annual retinal examination regardless of weight management, but more frequently if any visual symptoms develop.